Kivo Health, a US-based digital health company providing virtual care for chronic lung disease, announced a $10 million Series A funding round on October 27, 2026. The round was led by Allumia Ventures, with participation from Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures.
The financing brings the company’s total funding to more than $16 million.
Founded in 2021 by Victor Sadauskas and Vaughn Koch, Kivo Health develops AI-supported virtual healthcare services for patients with chronic respiratory conditions. Sadauskas serves as co-founder and CEO, while Koch is co-founder and CTO.
The company’s primary offering is a nine-week virtual pulmonary rehabilitation program designed for people living with chronic obstructive pulmonary disease (COPD). The program combines supervised exercise, breathing techniques, patient education and ongoing support through video-based sessions with clinical professionals.
Kivo Health delivers these services directly to patients’ homes, reducing the need to travel to rehabilitation facilities. Its technology platform also supports clinical teams in engaging patients between appointments and managing their respiratory conditions.
The company plans to use the Series A proceeds to expand its clinical operations across the United States, strengthen partnerships with health insurers and further develop its AI-powered care platform.
Kivo Health also intends to extend its care model beyond pulmonary rehabilitation, with plans to address additional chronic conditions affecting older adults.
The company has established healthcare partnerships with organizations including Stanford Health Care, Priority Health and Optum Arcadia to expand access to virtual respiratory care.
According to Kivo Health, a peer-reviewed study of its pulmonary rehabilitation program reported improvements in respiratory symptoms, functional capacity and mood, alongside an 83% median program attendance rate.
